The spectrum of primary liver cancers: heterogeneity and continuity. A foundation for diagnosis and treatment of cancer
Mina Komuta, Akihisa Ueno, Michiie Sakamoto – 8 March 2022
Gut Dysbiosis and Fecal Calprotectin Predict Response to Immune Checkpoint Inhibitors in Patients With Hepatocellular Carcinoma
Francesca Romana Ponziani, Angela De Luca, Anna Picca, Emanuele Marzetti, Valentina Petito, Federica Del Chierico, Sofia Reddel, Francesco Paroni Sterbini, Maurizio Sanguinetti, Lorenza Putignani, Antonio Gasbarrini, Maurizio Pompili – 8 March 2022 – The gut microbiota is a well‐known prognostic factor and a modulator of treatment sensitivity in patients with cancers treated with immune checkpoint inhibitors. However, data on hepatocellular carcinoma (HCC) are lacking.
Gut microbiota–derived short‐chain fatty acids regulate group 3 innate lymphoid cells in HCC
Chupeng Hu, Bingqing Xu, Xiaodong Wang, Wen‐Hua Wan, Jinying Lu, Deyuan Kong, Yu Jin, Wenhua You, Hua Sun, Xiaoxin Mu, Dongju Feng, Yun Chen – 8 March 2022
Nonselective Beta‐Blockers in Portal Hypertension: Why, When, and How?
Anahita Rabiee, Guadalupe Garcia‐Tsao, Elliot B. Tapper – 7 March 2022
Nonselective Beta‐Blockers in Portal Hypertension: Why, When, and How?
Anahita Rabiee, Guadalupe Garcia‐Tsao, Elliot B. Tapper – 7 March 2022
Letter to the editor: High rate of clinical and immunological response in patients with HCV‐associated cryoglobulinemia
Sofiia Gavrisheva, Dzhamal Abdurakhmanov, Svetlana Milovanova, Elena Nikulkina, Teona Rozina, Elena Tanashchuk, Ekaterina Nabatchikova, Nikolay Bulanov, Tatiana Krasnova, Sergey Moiseev – 7 March 2022
Low‐dose aspirin reduces the risk of HBV‐associated HCC even when administered short‐term: Too good to be true?
Luca G. Guidotti, Carlo La Vecchia, Massimo Colombo – 6 March 2022
Prediction of long‐term morbidity and mortality after liver transplantation using two‐dimensional shear wave elastography compared with liver biopsy
Mohammad Amin Fallahzadeh, Sumeet K. Asrani, Elham Vahhab, Vivian S. Ebrahim, Giovanna Saracino, Saleh Elwir, James F. Trotter – 6 March 2022 – The role of noninvasive liver disease assessment by two‐dimensional shear wave elastography (2D‐SWE) to diagnose fibrosis is well described in patients with chronic liver disease. However, its role in prognosis, especially after liver transplantation (LT) has not been adequately examined.
Hepatic inflammation elicits production of proinflammatory netrin‐1 through exclusive activation of translation
Romain Barnault, Claire Verzeroli, Carole Fournier, Maud Michelet, Anna Rita Redavid, Ievgeniia Chicherova, Marie‐Laure Plissonnier, Annie Adrait, Olga Khomich, Fleur Chapus, Mathieu Richaud, Maëva Hervieu, Veronika Reiterer, Federica Grazia Centonze, Julie Lucifora, Birke Bartosch, Michel Rivoire, Hesso Farhan, Yohann Couté, Valbona Mirakaj, Thomas Decaens, Patrick Mehlen, Benjamin Gibert, Fabien Zoulim, Romain Parent – 6 March 2022
Coagulopathy and hemostasis management in patients undergoing liver transplantation: Defining a dynamic spectrum across phases of care
Anjana A. Pillai, Michael Kriss, David P. Al‐Adra, Ryan M. Chadha, Melissa M. Cushing, Khashayar Farsad, Brett E. Fortune, Aaron S. Hess, Robert Lewandowski, Mitra K. Nadim, Trevor Nydam, Pratima Sharma, Constantine J. Karvellas, Nicolas Intagliata – 6 March 2022 – Patients with acute and chronic liver disease present with a wide range of disease states and severity that may require liver transplantation (LT). Physiologic alterations occur that are dynamic throughout all phases of perioperative care, creating complex management scenarios that necessitate multidisciplinary clinical care.